Synaptic remodeling during aging and in Alzheimer's disease

Journal of Alzheimer's Disease

Volumn 9, Issue SUPPL. 3, 2006, Pages 91-99

  Masliah, Eliezer ^a,b   Crews, Leslie ^a   Hansen, Lawrence ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid; A PP; Synapse loss; Synaptic plasticity

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE;

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PRIORITY JOURNAL; SYNAPSE;

EID: 33747391594     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/jad-2006-9s311     Document Type: Article

References (118)

1. I. Adams and D. Jones, Effects of normal and pathological aging on brain morphology: Neurons and synapses, in: Current topics in research on synapses, (Vol. 4), D. Jones and Alan R. Liss, eds, Inc., New York, 1987, pp. 16-17.
2. A. Alzheimer, Uber eine eigenartige Erkrankung der Hirnrinde, Algemeine Zeitschrift fur Psychiatric 64 (1907), 146-148.
3. B. Anderson, Dendritic correlates of dementia severity in Alzheimer's disease, Med. Sci. Res. 23 (1995), 597-599.
4. H. Arai, M. Schmidt, V.-Y. Lee, H. Hurtig, B. Greenberg, C. Adler and J. Trojanowski, Epitope analysis of senile plaque components in the hippocampus of patients with Parkinson's disease, Neurology 42 (1992), 1315-1322.
5. P. Arriagada, J. Growdon, E. Hedley-Whyte and B. Hyman, Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease, Neurology 42 (1992), 631-639.
6. J. Avila, F. Lim, F. Moreno, C. Belmonte and A.C. Cuello, Tau function and dysfunction in neurons: its role in neurodegenerative disorders, Mol Neurobiol 25 (2002), 213-231.
7. C. Bertoni-Freddari, P. Fattoretti, T. Casoli, F. Masera, W. Meier-Ruge and J. Ulrich, Computer-assisted morphometry of synaptic plasticity during aging and dementia, Path. Res. Pract. 185 (1989), 799-802.
8. C. Bertoni-Freddari, P. Fattoretti, A. Delfino, M. Solazzi, B. Giorgetti, J. Ulrich and W. Meier-Ruge, Deafferentative synaptopathology in physiological aging and Alzheimer's disease, Ann N Y Acad Sci 977 (2002), 322-326.
9. K. Blennow, N. Bogdanovic, I. Alafuzoff, R. Ekman and P. Davidsson, Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele, J. Neural Transm. 103 (1996), 603-618.
10. E. Braak, H. Braak and E. Mandelkow, A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads, Acta Neuropathol. (Berl) 87 (1994), 554-567.
11. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol 82 (1991), 239-259.
12. S.L. Chan, K. Furukawa and M.P. Mattson, Presenilins and APP in neuritic and synaptic plasticity: implications for the pathogenesis of Alzheimer's disease, Neuromolecular Med 2 (2002), 167-196.
13. M.-C. Chartier-Harlin, F. Crawford, H. Houlden, A. Warren, D. Hughes, L. Fidani, A. Goate, M. Rossor, P. Roques, J. Hardy and M. Mullan, Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene, Nature 353 (1991), 844-846.
14. J. Chin, J.J. Palop, G.Q. Yu, N. Kojima, E. Masliah and L. Mucke, Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice, J Neurosci 24 (2004), 4692-4697.
15. J.H. Choi and B.P. Yu, Brain synaptosomal aging: free radicals and membrane fluidity, Free Radic Biol Med 18 (1995), 133-139.
16. L. Cork, C. Masters, K. Beyreuther and D. Price, Development of senile plaques. Relationships of neuronal abnormalities and amyloid deposits, Am. J. Pathol. 137 (1990), 1383-1392.
17. L. Cork and D. Price, Relationships of abnormal neuronal processes and amyloid in plaques in aged monkeys, J. Neuropathol. Exp. Neurol. 49 (1990), 309.
18. B. Cummings, J. Su, J. Geddes, W. Van Norstrand, S. Wagner, D. Cunningham and C. Cotman, Aggregation of the amyloid precursor protein within degenerating neurons and dystrophic neurites in Alzheimer's disease, Neurosci 48 (1992), 763-777.
19. C. Davies, D. Mann, P. Sumpter and P. Yates, A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease, J. Neurol. Sci. 78 (1987), 151-164.
20. S. DeKosky and S. Scheff, Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity, Ann. Neurol. 27 (1990), 457-464.
21. D. Dickson, H. Crystal, C. Bevona, W. Honer, I. Vincent and P. Davies, Correlations of synaptic and pathological markers with cognition of the elderly, Neurobiol. Aging 16 (1995), 285-304.
22. D. Dickson, J. Farlo, P. Davies, H. Crystal, P. Fuld and S. Yen, Alzheimer disease. A double immunohistochemical study of senile plaques, Am. J. Pathol. 132 (1988), 86-101.
23. K. Duff, C. Eckman, C. Zehr, X. Yu, C. Prada, J. Perez-Tur, M. Hutton, L. Buee, Y. Harigaya, D. Yager, D. Morgan, M. Gordon, L. Holcomb, L. Refolo, B. Zenk, J. Hardy and S. Younkin, Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1, Nature 383 (1996), 710-713.
24. J. Eccles, The cerebral neocortex: a theory of its operation, in: Cerebral Cortex, (Vol. 2), Functional properties of cortical cells, E. Jones and A. Peters, eds, Plenum Press, New York, 1984, pp. 1-38.
25. W.P. Esler and M.S. Wolfe, A portrait of Alzheimer secretases-new features and familiar faces, Science 293 (2001), 1449-1454.
26. H. Fukumoto, B.S. Cheung, B.T. Hyman and M.C. Irizarry, β-secretase protein and activity are increased in the neocortex in Alzheimer disease, Arch Neurol 59 (2002), 1381-1389.
27. D. Galasko, L. Hansen, R. Katzman, W. Wiederholt, E. Masliah, R. Terry, L. Hill, P. Lessin and L. Thal, Clinical-neuropathological correlations in Alzheimer's disease and related dementias, Arch. Neurol. 51 (1994), 888-895.
28. M. Gearing, S. Mirra, J. Hedreen, S. Sumi, L. Hansen and A. Heyman, Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease: CERAD. Part X, Neurology 45 (1995), 461-466.
29. J. Geddes, K. Anderson and C. Cotman, Senile plaques as aberrant sprout stimulating structures, Exp. Neurol. 94 (1986), 767-776.
30. Y. Geinisman, O. Ganeshina, R. Yoshida, R. W. Berry, J. F. Disterhoft and M. Gallagher, Aging, spatial learning, and total synapse number in the rat CA1 stratum radiatum, Neurobiol Aging 25 (2004), 407-416.
31. P. Gibson, EM study of the number of cortical synapses in the brains of ageing people and people with Alzheimer-type dementia, Acta Neuropathol. Berl 62 (1983), 127-133.
32. A. Goate, M.-C. Chartier-Harlin, M. Mullan, J. Brown, F. Crawford, L. Fidani, L. Guiffra, A. Haynes, N. Irving, L. James, R. Mant, P. Newton, K. Rooke, P. Roques, C. Talbot, R. Williamson, M. Rossor, M. Owen and J. Hardy, Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease, Nature 349 (1991), 704.
33. N. Gonatas, W. Anderson and I. Evangelista, The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's disease, J. Neuropathol. Exp. Neurol. 26 (1967), 25-39.
34. N. Gonatas and P. Gambetti, The pathology of the synapse in: Alzheimer's disease. Ciba Foundation Symposium on Alzheimer's disease and related conditions, G. Wolstenholme and O. London, eds, J & A Churchill, 1970.
35. E.A. Grace, C.A. Rabiner and J. Busciglio, Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer's disease, Neuroscience 114 (2002), 265-273.
36. K.H. Gylys, J.A. Fein, F. Yang, D.J. Wiley, C.A. Miller and G.M. Cole, Synaptic changes in Alzheimer's disease: increased amyloid-β and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence, Am J Pathol 165 (2004), 1809-1817.
37. C. Haas, A.Y. Hung, M. Citron, D.B. Teplow and D.J. Selkoe, β-Amyloid, protein processing and Alzheimer's disease, Arzneimittelforschung 45 (1995), 398-402.
38. J. Hamos, L. DeGennaro and D. Drachman, Synaptic loss in Alzheimer's disease and other dementias, Neurology 39 (1989), 355-361.
39. J. Hardy and A. Israel, Alzheimer's disease. In search of γ-secretase, Nature 398 (1999), 466-467.
40. H. Haug, S. Kuhl, E. Mecke, N. Sass and K. Wasner, The significance of morphometric procedures in the investigation of age changes in cytoarchitectonic structures of human brain, J. Hirnforsch. 25 (1984), 353-374.
41. P. Hof and J. Morrison, The cellular basis of cortical disconnection in Alzheimer disease and related dementing conditions, in: Alzheimer disease, R. Terry, R. Katzman and K. Bick, eds, Raven Press, New York, 1994, pp. 197-230.
42. P.R. Hof and J.H. Morrison, The aging brain: morphomolecular senescence of cortical circuits, Trends Neurosci 27 (2004), 607-613.
43. R.M. Holsinger, C.A. McLean, K. Beyreuther, C.L. Masters and G. Evin, Increased expression of the amyloid precursor β-secretase in Alzheimer's disease, Ann Neurol 51 (2002), 783-786.
44. A.J. Holtmaat, J.T. Trachtenberg, L. Wilbrecht, G.M. Shepherd, X. Zhang, G.W. Knott and K. Svoboda, Transient and persistent dendritic spines in the neocortex in vivo, Neuron 45 (2005), 279-291.
45. J.T. Huse, K. Liu, D.S. Pijak, D. Carlin, V.M. Lee and R.W. Doms, β-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain, J Biol Chem 277 (2002), 16278-16284.
46. P. Huttenlocher, Synaptic density in human frontal cortex - developmental changes and effects of aging, Brain Res 163 (1979), 195-205.
47. B. Hyman, G. Van Hoesen, L. Kromer and A. Damasio, Perforant pathway changes in the memory impairment of Alzheimer's disease, Ann. Neurol. 20 (1986), 472-481.
48. D. Jones and R. Harris, An analysis of contemporary morphological concepts of synaptic remodelling in the CNS: Perforated synapses revisited, Rev. Neurosci. 6 (1995), 177-219.
49. F. Kamenetz, T. Tomita, H. Hsieh, G. Seabrook, D. Borchelt, T. Iwatsubo, S. Sisodia and R. Malinow, APP Processing and synaptic function, Neuron 37 (2003), 925-937.
50. R. Katzman, Alzheimer's disease is a degenerative disorder, Neurobiol. Aging 10 (1989), 581-582-588-590.
51. Z. Khachaturian, Diagnosis of Alzheimer's disease, Arch. Neurol. 42 (1985), 1097-1105.
52. W.L. Klein, Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets, Neurochem Int 41 (2002), 345-352.
53. E. Koo, P.J. Lansbury and J. Kelly, Amyloid diseases: Abnormal protein aggregation in neurodegeneration, Proc. Natl. Acad. Sci. USA 96 (1999), 9989-9990.
54. E. Koo, L. Park and D. Selkoe, Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth, Proc. Natl. Acad. Sci. USA 90 (1993), 4749-4752.
55. P.N. Lacor, M.C. Buniel, L. Chang, S.J. Fernandez, Y. Gong, K.L. Viola, M.P. Lambert, P.T. Velasco, E.H. Bigio, C.E. Finch, G.A. Krafft and W.L. Klein, Synaptic targeting by Alzheimer's-related amyloid β oligomers, J Neurosci 24 (2004), 10191-10200.
56. H.A. Lashuel, D.M. Hartley, B.M. Petre, J.S. Wall, M.N. Simon, T. Walz and P.T. Lansbury, Jr., Mixtures of wild-type and a pathogenic (E22G) form of Aβ40 in vitro accumulate protofibrils, including amyloid pores, J Mol Biol 332 (2003), 795-808.
57. H. Lassmann, R. Weiler, P. Fischer, C. Bancher, K. Jellinger, E. Floor, W. Danielczyk, F. Seitelberger and H. Winkler, Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles, Neurosci 46 (1992), 1-8.
58. H.G. Lee, P.I. Moreira, X. Zhu, M.A. Smith and G. Perry, Staying connected: synapses in Alzheimer disease, Am J Pathol 165 (2004), 1461-1464.
59. C. Lippa, J. Hamos, D. Pulaski-Salo, L. DeGennaro and D. Drachman, Alzheimer's disease and aging: Effects on perforant pathway perikarya and synapses, Neurobiol. Aging 13 (1992), 405-411.
60. X. Liu, C. Erikson and A. Brun, Cortical synaptic changes and gliosis in normal aging, Alzheimer's disease and frontal lobe degeneration, Dementia 7 (1996), 128-134.
61. L. Martin, C. Pardo, L. Cork and D. Price, Synaptic pathology and glial reponses to neuronal injury precede the formation of senile plaques and amyloid deposits in the aging cerebral cortex, Am. J. Pathol. 145 (1994), 1358-1381.
62. E. Masliah, Mechanisms of synaptic pathology in Alzheimer's disease, J. Neural. Transm. 53 (Suppl) (1998), 147-158.
63. E. Masliah, The natural evolution of the neurodegenerative alterations in Alzheimer's disease, Neurobiol. Aging 16 (1995), 280-282.
64. E. Masliah, M. Alford, A. Adame, E. Rockenstein, D. Galasko, D. Salmon, L.A. Hansen and L.J. Thal, Aβ1-42 promotes cholinergic sprouting in patients with AD and Lewy body variant of AD, Neurology 61 (2003), 206-211.
65. E. Masliah, L. Hansen, T. Albright, M. Mallory and R. Terry, Immunoelectron microscopic study of synaptic pathology in Alzheimer disease, Acta Neuropathol 81 (1991), 428-433.
66. E. Masliah, W. Honer, M. Mallory, M. Voigt, P. Kushner and R. Terry, Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer disease hippocampus, Acta Neuropathol 87 (1994), 135-142.
67. E. Masliah and F. LiCastro, Neuronal and synaptic loss, reactive gliosis, microglial response, and induction of the complement cascade in Alzheimer's disease, in: Neurodegenerative dementias, C. Clark and J. Trojanowski, eds, McGraw-Hill, New York, NY, 2000, pp. 131-146.
68. E. Masliah, M. Mallory, M. Alford, R. DeTeresa, L.A. Hansen, D.W. McKeel, Jr. and J.C. Morris, Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease, Neurology 56 (2001), 127-129.
69. E. Masliah, M. Mallory, R. DeTeresa, M. Alford and L. Hansen, Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodies, Brain Res 617 (1993), 258-266.
70. E. Masliah, M. Mallory, N. Ge and T. Saitoh, Amyloid precursor protein is localized in growing neurites of neonatal rat brain, Brain Res 593 (1992), 323-328.
71. E. Masliah, M. Mallory, L. Hansen, M. Alford, T. Albright, R. DeTeresa, R. Terry, J. Baudier and T. Saitoh, Patterns of aberrant sprouting in Alzheimer disease, Neuron 6 (1991), 729-739.
72. E. Masliah, M. Mallory, L. Hansen, R. DeTeresa, M. Alford and R. Terry, Synaptic and neuritic alterations during the progression of Alzheimer's disease, Neurosci. Lett. 174 (1994), 67-72.
73. E. Masliah, M. Mallory, L. Hansen, R. DeTeresa and R. Terry, Quantitative synaptic alterations in the human neocortex during normal aging, Neurology 43 (1993), 192-197.
74. E. Masliah, J. Raber, M. Alford, M. Mallory, M. Mattson, C. Westland and L. Mucke, Regulation of excitatory amino acid transporters by amyloid protein precursor (APP) and its relations to neuroprotective APP effects in transgenic mice, J. Biol. Chem. (1997).
75. E. Masliah, E. Rockenstein, I. Veinbergs, Y. Sagara, M. Mallory, M. Hashimoto and L. Mucke, b amyloid peptides enhance a-synuclein accumulation and neuronal deficits in a transgenic mouse model likning Alzheimer's and Parkinson's disease, Proc Natl Acad Sci USA 98 (2001), 12245-12250.
76. E. Masliah and D. Salmon, Neuropathological correlates of dementia in Alzheimer's disease, in: Cerebral Cortex. Neurodegenerative and age-related changes in structure and function of cerebral cortex, (Vol. 14), A. Peters and J. Morrison, eds, Plenum Publishers, New York, NY, 1999, pp. 513-551.
77. E. Masliah, A. Sisk, M. Mallory, L. Mucke, D. Schenk and D. Games, Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F b-amyloid precursor protein and Alzheimer's disease, J. Neurosci. 16 (1996), 5795-5811.
78. E. Masliah and R. Terry, The role of synaptic pathology in the mechanisms of dementia in Alzheimer's disease, Clin. Neurosci. 1 (1994), 192-198.
79. E. Masliah, R. Terry, M. Alford, R. DeTeresa and L. Hansen, Cortical and subcortical patterns of synaptophysin-like immunoreactivity in Alzheimer disease, Am. J. Pathol. 138 (1991), 235-246.
80. E. Masliah, R. Terry, R. DeTeresa and L. Hansen, Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer disease, Neurosci. Lett. 103 (1989), 234-239.
81. M.P. Mattson, Apoptosis in neurodegenerative disorders, Nat. Rev. Mol. Cell. Biol. 1 (2000), 120-129.
82. M.P. Mattson, Oxidative stress, perturbed calcium homeostasis, and immune dysfunction in Alzheimer's disease, J Neurovirol 8 (2002), 539-550.
83. R. Mileusnic, C.L. Lancashire, A.N. Johnston and S.P. Rose, APP is required during an early phase of memory formation, Eur J Neurosci 12 (2000), 4487-4495.
84. L. Mucke, E. Masliah, G. Q. Yu, M. Mallory, E. M. Rockenstein, G. Tatsuno, K. Hu, D. Kholodenko, K. Johnson-Wood and L. McConlogue, High-level neuronal expression of Aβ 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation, J Neurosci 20 (2000), 4050-1058.
85. P. Patterson, Process outgrowth and the specificity of connections, in: An introduction to molecular neurobiology, Z. Hall, ed., Sinauer Associates, Inc, Sunderland, Massachusetts, 1992, pp. 388-427.
86. A. Peters, C. Sethares and M.B. Moss, The effects of aging on layer 1 in area 46 of prefrontal cortex in the rhesus monkey, Cereb Cortex 8 (1998), 671-684.
87. J.L. Price, D.W. McKeel, Jr. and J.C. Morris, Synaptic loss and pathological change in older adults-aging versus disease? Neurobiol Aging 22 (2001), 351-352.
88. S. Rossner, J. Apelt, R. Schliebs, J. R. Perez-Polo and V. Bigl, Neuronal and glial β-secretase (BACE) protein expression in transgenic Tg2576 mice with amyloid plaque pathology, J Neurosci Res 64 (2001), 437-446.
89. D. Salmon, L. Thal, N. Butters and W. Heindel, Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standarized mental status examinations, Neurology 40 (1990), 1225-1230.
90. W. Samuel, E. Masliah and R. Terry, Hippocampal connectivity and Alzheimer's dementia: effects of pathology in a two-component model, Neurology 44 (1994), 2081-2088.
91. S. Scheff, S. DeKosky and D. Price, Quantitative assessment of cortical synaptic density in Alzheimer's disease, Neurobiol. Aging 11 (1990), 29-37.
92. S. Scheff and D. Price, Synapse loss in the temporal lobe in Alzheimer's disease, Ann. Neurol. 33 (1993), 190-199.
93. S. Scheff, D. Sparks and D. Price, Quantitative assessment of synaptic density in the entorhinal cortex in Alzheimer's disease, Ann. Neurol. 34 (1993), 356-361.
94. S.W. Scheff and D.A. Price, Alzheimer's disease-related synapse loss in the cingulate cortex, J Alzheimers Dis 3 (2001), 495-505.
95. S.W. Scheff and D.A. Price, Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies, Neurobiol Aging 24 (2003), 1029-1046.
96. D.J. Selkoe, Alzheimer's disease is a synaptic failure, Science 298 (2002), 789-791.
97. D.J. Selkoe, T. Yamazaki, M. Citron, M.B. Podlisny, E.H. Koo, D.B. Teplow and C. Haass, The role of APP processing and trafficking pathways in the formation of amyloid β-protein, Ann N Y Acad Sci 777 (1996), 57-64.
98. S. Sinha, J. Anderson, V. John, L. McConlogue, G. Basi, E. Thorsett and D. Schenk, Recent advances in the understanding of the processing of APP to β amyloid peptide, Ann N Y Acad Sci 920 (2000), 206-208.
99. S. Sinha, J.P. Anderson, R. Barbour, G.S. Basi, R. Caccavello, D. Davis, M. Doan, H.F. Dovey, N. Frigon, J. Hong, K. Jacobson-Croak, N. Jewett, P. Keim, J. Knops, I. Lieberburg, M. Power, H. Tan, G. Tatsuno, J. Tung, D. Schenk, P. Seubert, S.M. Suomensaari, S. Wang, D. Walker, V. John et al., Purification and cloning of amyloid precursor protein β-secretase from human brain, Nature 402 (1999), 537-540.
100. J. Six, U. Lubke, M.-B. Lenders, M. Vandermeeren, M. Mercken, M. Villanova, A. Van de Voorde, J. Gheuenst, J.-J. Martin and P. Cras, Neurite sprouting and cytoskeletal pathology in Alzheimer's disease: a comparative study with monoclonal antibodies to growth-associated protein B-50 (GAP43) and paired helical filaments, Neurodegeneration 1 (1992), 247-255.
101. P.H. St George-Hyslop and A. Petit, Molecular biology and genetics of Alzheimer's disease, C R Biol 328 (2005), 119-130.
102. C.I. Sze, J.C. Troncoso, C. Kawas, P. Mouton, D.L. Price and L.J. Martin, Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease, J. Neuropathol. Exp. Neurol. 56 (1997), 933-944.
103. R.H. Takahashi, T.A. Milner, F. Li, E.E. Nam, M.A. Edgar, H. Yamaguchi, M.F. Beal, H. Xu, P. Greengard and G.K. Gouras, Intraneuronal Alzheimer Aβ42 accumulates in multivesicular bodies and is associated with synaptic pathology, Am J Pathol 161 (2002), 1869-1879.
104. R. Tanzi, J. Gusella, P. Watkins, G. Bruns, P. St.George-Hyslop, M. van Keuren, D. Patterson, S. Pagan, D. Kurnik and R. Neve, Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus, Science 235 (1987), 880-884.
105. R. Terry, R. DeTeresa and L. Hansen, Neocortical cell counts in normal human adult aging, Ann. Neurol. 21 (1987), 530-539.
106. R. Terry, N. Gonatas and M. Weiss, Ultrastructural studies in Alzheimer's presenile dementia, Am. J. Pathol. 44 (1964), 269-297.
107. R. Terry, L. Hansen and E. Masliah, Structural basis of the cognitive alterations in Alzheimer disease, in: Alzheimer disease, R. Terry and R. Katzman, eds, Raven Press, New York, 1994, pp. 179-196.
108. R. Terry, E. Masliah, D. Salmon, N. Butters, R. DeTeresa, R. Hill, L. Hansen and R. Katzman, Physical basis of cognitive alterations in Alzheimer disease: synapse loss is the major correlate of cognitive impairment, Ann. Neurol. 30 (1991), 572-580.
109. R.D. Terry and R. Katzman, Life span and synapses: will there be a primary senile dementia? Neurobiol Aging 22 (2001), 347-348; discussion 353-354.
110. B. Trapp, P. Hauer, C. Haney and D. Wirak, APP is expressed in fetal brain and is associated with neuronal development, J. Neuropathol. Exp. Neurol. 51 (1992), 358.
111. R. Vassar, B.D. Bennett, S. Babu-Khan, S. Kahn, E.A. Mendiaz, P. Denis, D.B. Teplow, S. Ross, P. Amarante, R. Loeloff, Y. Luo, S. Fisher, J. Fuller, S. Edenson, J. Lile, M.A. Jarosinski, A.L. Biere, E. Curran, T. Burgess, J.C. Louis, F. Collins, J. Treanor, G. Rogers and M. Citron, β-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE, Science 286 (1999), 735-741.
112. K. Wakabayashi, W. Honer and E. Masliah, Synapse alterations in the hippocampal-entorhinal formation in Alzheimer's disease with and without Lewy body disease, Brain Res 667 (1994), 24-32.
113. D.M. Walsh, I. Klyubin, J.V. Fadeeva, M.J. Rowan and D.J. Selkoe, Amyloid-β oligomers: their production, toxicity and therapeutic inhibition, Biochem Soc Trans 30 (2002), 552-557.
114. R. Weiler, H. Lassmann, P. Fischer, K. Jellinger and H. Winkler, A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick disease, FEBS Lett 263 (1990), 337-339.
115. B. Yankner, L. Duffy and D. Kirschner, Neurotrophic and neurotoxic effects of amyloid b protein: reversal by tachykinin neuropeptides, Science 250 (1990), 279-282.
116. P.J. Yao, M. Zhu, E.I. Pyun, A.I. Brooks, S. Therianos, V.E. Meyers and P.D. Coleman, Defects in expression of genes related to synaptic vesicle traffickingin frontal cortex of Alzheimer's disease, Neurobiol Dis 12 (2003), 97-109.
117. S.G. Younkin, The AAP and PS1/2 mutations linked to early onset familial Alzheimer's disease increase the extracellular concentration and Aβ 1-42 (43), Rinsho Shinkeigaku 37 (1997), 1099.
118. S. Zhan, K. Beyreuther and H. Schmitt, Quantitative assessment of the synaptophysin immuno-reactivity of the cortical neuropil in various neurodegenerative disorders with dementia, Dementia 4 (1993), 66-74.